Azilect
Rasagiline mesylate
- Strength
- 1 mg/1
- Form
- Tablet
- Class
- Monoamine Oxidase Inhibitor
Teva Neuroscience, Inc.
Not stocked by us — reference only
Listed by Teva Pharmaceuticals USA, Inc.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Monoamine Oxidase Inhibitor |
| Approval route | Authorised generic |
| NDC code | 0093-3060 |
| FDA application | NDA021641 |
| RxNorm concept | 608328 |
| Package sizes listed | 1 |
| Marketed since | January 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Rasagiline mesylate
Teva Neuroscience, Inc.
Not stocked by us — reference only
Rasagiline mesylate
Teva Neuroscience, Inc.
Not stocked by us — reference only
Torrent Pharmaceuticals Limited
Not stocked by us — reference only
Torrent Pharmaceuticals Limited
Not stocked by us — reference only
NorthStar RxLLC
Not stocked by us — reference only
NorthStar RxLLC
Not stocked by us — reference only
Chartwell RX, LLC
Not stocked by us — reference only
Rasagiline mesylate
SKG Pharma Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.